GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (CHIX:VITRs) » Definitions » Gross Margin %

Vitrolife AB (CHIX:VITRS) Gross Margin % : 57.19% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vitrolife AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Vitrolife AB's Gross Profit for the three months ended in Mar. 2024 was kr481 Mil. Vitrolife AB's Revenue for the three months ended in Mar. 2024 was kr841 Mil. Therefore, Vitrolife AB's Gross Margin % for the quarter that ended in Mar. 2024 was 57.19%.

Warning Sign:

Vitrolife AB gross margin has been in long-term decline. The average rate of decline per year is -3.4%.


The historical rank and industry rank for Vitrolife AB's Gross Margin % or its related term are showing as below:

CHIX:VITRs' s Gross Margin % Range Over the Past 10 Years
Min: 55.04   Med: 64.29   Max: 68.39
Current: 56.39


During the past 13 years, the highest Gross Margin % of Vitrolife AB was 68.39%. The lowest was 55.04%. And the median was 64.29%.

CHIX:VITRs's Gross Margin % is ranked better than
55.85% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 52.61 vs CHIX:VITRs: 56.39

Vitrolife AB had a gross margin of 57.19% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Vitrolife AB was -3.40% per year.


Vitrolife AB Gross Margin % Historical Data

The historical data trend for Vitrolife AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Gross Margin % Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.42 61.63 62.22 55.04 56.29

Vitrolife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.79 55.80 55.78 56.80 57.19

Competitive Comparison of Vitrolife AB's Gross Margin %

For the Medical Devices subindustry, Vitrolife AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Gross Margin % falls into.



Vitrolife AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Vitrolife AB's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=1977 / 3512
=(Revenue - Cost of Goods Sold) / Revenue
=(3512 - 1535) / 3512
=56.29 %

Vitrolife AB's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=481 / 841
=(Revenue - Cost of Goods Sold) / Revenue
=(841 - 360) / 841
=57.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Vitrolife AB  (CHIX:VITRs) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Vitrolife AB had a gross margin of 57.19% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Vitrolife AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (CHIX:VITRS) Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (CHIX:VITRS) Headlines

No Headlines